Gratus Wealth Advisors’s AbbVie ABBV Stock Holding History

Gratus Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Sell	6,406 -21	-0.3%	-$4.52K	0.21%	38
2026 Q1	$1.4M	Buy	6,427 +403	+7%	+$89.4K	0.2%	42
2025 Q4	$1.38M	Sell	6,024 -324	-5%	-$73.8K	0.19%	48
2025 Q3	$1.47M	Sell	6,348 -104	-2%	-$21.2K	0.21%	41
2025 Q2	$1.2M	Buy	6,452 +104	+2%	+$19.3K	0.18%	50
2025 Q1	$1.33M	Sell	6,348 -178	-3%	-$34.6K	0.22%	42
2024 Q4	$1.16M	Sell	6,526 -916	-12%	-$168K	0.19%	52
2024 Q3	$1.44M	Hold	7,442	–	–	0.24%	45
2024 Q2	$1.28M	Sell	7,442 -146	-2%	-$24.2K	0.22%	43
2024 Q1	$1.25M	Buy	7,588 +187	+3%	+$32.2K	0.23%	44
2023 Q4	$1.15M	Buy	+7,401	New	+$1.08M	0.23%	48

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Gratus Wealth Advisors's ABBV Position: Q2 2026 in Review

Gratus Wealth Advisors reduced its AbbVie (ABBV) stake by 0.33% in Q2 2026, selling an estimated $4.52K and leaving 6,406 shares worth $1.61M. The position accounts for 0.21% of the portfolio, ranked #38.

Gratus Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Gratus Wealth Advisors held 6,406 shares of AbbVie worth $1.61M as of Q2 2026.
Gratus Wealth Advisors sold 21 AbbVie shares in Q2 2026, an estimated $4.52K.
AbbVie made up 0.21% of Gratus Wealth Advisors's portfolio in Q2 2026, its #38 holding.
Gratus Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gratus Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.